Filing Details

Accession Number:
0001562180-19-004967
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-27 16:05:30
Reporting Period:
2019-09-25
Accepted Time:
2019-09-27 16:05:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1685071 Dova Pharmaceuticals Inc. DOVA Pharmaceutical Preparations (2834) 813858961
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1709417 Kevin Laliberte C/O Dova Pharmaceuticals, Inc.
240 Leigh Farm Road, Suite 245
Durham NC 27707
Sr. Vp, Product Development No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-09-25 3,100 $20.00 8,457 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan based on a limit price order adopted by the Reporting Person.